FDA Joins NIH and EPA in Tox21 Effort | GenomeWeb

This article has been updated with quotes and additional information from NCGC Director Christopher Austin.

By Matt Jones

NEW YORK (GenomeWeb News) – The Tox21 program that brings together the National Institutes of Health and the Environmental Protection Agency to develop new ways to predict the effects of chemicals on humans and the environment has gained a new partner in the US Food and Drug Administration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.